quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:10:45·8d
ANALYSTRating
Tyra Biosciences Inc. logo

Guggenheim initiated coverage on Tyra Biosciences with a new price target

TYRA· Tyra Biosciences Inc.
Health Care
Original source

Companies

  • TYRA
    Tyra Biosciences Inc.
    Health Care

Recent analyst ratings

  • Apr 15UpdateGuggenheim$54.00
  • Apr 6UpdateCanaccord Genuity$50.00
  • Feb 24UpdateCantor Fitzgerald-
  • Feb 10UpdateWilliam Blair-
  • Jan 28UpdateBarclays$59.00
  • Sep 3UpdateRaymond James$35.00

Related

  • INSIDER3d
    SEC Form 4 filed by Dable Habib J
  • INSIDER3d
    SEC Form 3 filed by new insider Dable Habib J
  • SEC6d
    SEC Form DEFA14A filed by Tyra Biosciences Inc.
  • SEC6d
    SEC Form DEF 14A filed by Tyra Biosciences Inc.
  • SEC6d
    SEC Form 8-K filed by Tyra Biosciences Inc.
  • PR6d
    Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
  • SEC16d
    SEC Form SCHEDULE 13G filed by Tyra Biosciences Inc.
  • ANALYST17d
    Canaccord Genuity initiated coverage on Tyra Biosciences with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022